Physicochemical Properties
| Molecular Formula | C22H22CL2N2O7S |
| Molecular Weight | 529.39 |
| Exact Mass | 528.052 |
| CAS # | 2667628-25-1 |
| PubChem CID | 164610940 |
| Appearance | White to off-white solid powder |
| LogP | 2.7 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 7 |
| Heavy Atom Count | 34 |
| Complexity | 712 |
| Defined Atom Stereocenter Count | 5 |
| SMILES | CN1C(=NC2=CC=C(C=C21)C(=O)O)CO[C@H]1[C@H]([C@H](O[C@@H]([C@@H]1O)SC1C=CC(=C(C=1)Cl)Cl)CO)O |
| InChi Key | FKJDXCHMRVVEIN-DIINWTLSSA-N |
| InChi Code | InChI=1S/C22H22Cl2N2O7S/c1-26-15-6-10(21(30)31)2-5-14(15)25-17(26)9-32-20-18(28)16(8-27)33-22(19(20)29)34-11-3-4-12(23)13(24)7-11/h2-7,16,18-20,22,27-29H,8-9H2,1H3,(H,30,31)/t16-,18+,19-,20+,22-/m1/s1 |
| Chemical Name | 2-[[(2R,3R,4S,5S,6R)-2-(3,4-dichlorophenyl)sulfanyl-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxymethyl]-3-methylbenzimidazole-5-carboxylic acid |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | Galectin-8 |
| References |
[1]. Benzimidazole-galactosides bind selectively to the Galectin-8 N-Terminal domain: Structure-based design and optimisation. Eur J Med Chem. 2021 Nov 5;223:113664. |
Solubility Data
| Solubility (In Vitro) | DMSO: ≥ 50 mg/mL (94.45 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 1 mg/mL (1.89 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.8890 mL | 9.4448 mL | 18.8897 mL | |
| 5 mM | 0.3778 mL | 1.8890 mL | 3.7779 mL | |
| 10 mM | 0.1889 mL | 0.9445 mL | 1.8890 mL |